Search

Search results

4466 results found

Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.

Publication: Journal Article

Ney, Denise M, Angela K Hull, Sandra C van Calcar, Xiaowen Liu, and Mark R Etzel. 2008. “Dietary Glycomacropeptide Supports Growth and Reduces the Concentrations of Phenylalanine in Plasma and Brain in a Murine Model of Phenylketonuria.”. The Journal of Nutrition 138 (2): 316-22.

Insulin-like growth factor-I (IGF-I) attenuates jejunal atrophy in association with increased expression of IGF-I binding protein-5 in parenterally fed mice.

Publication: Journal Article

Murali, Sangita G, David W Nelson, Angela K Draxler, Xiaowen Liu, and Denise M Ney. 2005. “Insulin-Like Growth Factor-I (IGF-I) Attenuates Jejunal Atrophy in Association With Increased Expression of IGF-I Binding Protein-5 in Parenterally Fed Mice.”. The Journal of Nutrition 135 (11): 2553-9.

About BIDMC Research Student Positions

Page

All student research opportunities, paid or unpaid, require onboarding. Students conducting research need to either be employees (paid) or contingent workers (unpaid), regardless of the research they will be doing and systems they need to access to. All research positions should be a minimum of 8...

Scholarly Projects

Link

BIDMC is an exciting place to conduct research, and we want to be the host site for your HMS scholarly project requirement! Below, you can find a list of Principal Investigators and project opportunities currently available for scholarly projects. These offerings are continuously updated. If you are...

Mortality and readmissions after ventricular tachycardia ablation: An analysis of inpatient and outpatient state databases.

Publication: Journal Article

Brodeur, Peter G, Enrico G Ferro, Timothy G Maher, Jonathan W Waks, Andre D’Avila, ZhaoNian Zheng, Peter J Zimetbaum, et al. 2025. “Mortality and Readmissions After Ventricular Tachycardia Ablation: An Analysis of Inpatient and Outpatient State Databases.”. Heart Rhythm.

Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial.

Publication: Journal Article

Butala, Neel M, Christina Lalani, Archana Tale, Yang Song, Dhaval Kolte, Suzanne Baron, Jordan Strom, David J Cohen, and Robert W Yeh. 2025. “Use of Claims to Assess Outcomes and Treatment Effects in the Evolut Low Risk Trial.”. Circulation. Cardiovascular Interventions 18 (1): e014592.

Out-of-Pocket Savings Under the Inhaler Price Cap.

Publication: Journal Article

Mein, Stephen A, Ave K Kludze, William B Feldman, Archana P Tale, Jennifer P Stevens, and Rishi K Wadhera. 2025. “Out-of-Pocket Savings Under the Inhaler Price Cap.”. JAMA Internal Medicine 185 (3): 339-41.

Changes in Patient Care Experience After Private Equity Acquisition of US Hospitals.

Publication: Journal Article

Bhatla, Anjali, Victoria L Bartlett, Michael Liu, ZhaoNian Zheng, and Rishi K Wadhera. 2025. “Changes in Patient Care Experience After Private Equity Acquisition of US Hospitals.”. JAMA 333 (6): 490-97.

Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trial.

Publication: Journal Article

DeJong, Colette, Matthew S Durstenfeld, Jonathan D Davis, Christina S Wang, Elise D Riley, Mark D Huffman, Matthew D Hickey, et al. 2025. “Delivering Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction As an Over-Encapsulated Polypill: Rationale and Protocol for the COMBO-HF-X Pilot Crossover Randomised Clinical Trial.”. BMJ Open 15 (3): e093663.

Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy for Heart Failure With Reduced Ejection Fraction.

Publication: Journal Article

DeJong, Colette, Kosuke Inoue, Matthew S Durstenfeld, Anubha Agarwal, Justin C Chen, Chien-Wen Tseng, Adams Dudley, Priscilla Y Hsue, and Dhruv S Kazi. 2025. “Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy For Heart Failure With Reduced Ejection Fraction.”. JACC. Heart Failure.